The clinical utility of the combination of T stage and venous invasion to predict survival in patients undergoing surgery for colorectal cancer

Annals of Surgery

Volumn 259, Issue 6, 2014, Pages 1156-1165

  Roxburgh, Campbell S D ^a   Mcmillan, Donald C ^a   Richards, Colin H ^a   Atwan, Manal ^b   Anderson, John H ^a   Harvey, Tim ^b   Horgan, Paul G ^a   Foulis, Alan K ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Blood vessel; Colon cancer; Metastasis; Tumor staging; Venous invasion

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STAINING; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; TUMOR INVASION; VENOUS INVASION;

AGED; COLECTOMY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; LAPAROTOMY; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; VASCULAR NEOPLASMS; VEINS;

EID: 84900842838     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000229     Document Type: Article

References (35)

1. Cancer Research UK. Bowel cancer-UK incidence statistics. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/bowel/incidence/. Accessed September 27, 2013
2. McArdle CS, Hole DJ. Outcome following surgery for colorectal cancer. Br Med Bull. 2002;64:119-125
3. Mehrkhani F, Nasiri S, Donboli K, et al. Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Dis. 2009;11:157-161
4. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322: 352-358
5. Beart RW, Jr, Moertel CG, Wieand HS, et al. Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of theMayo Clinic and the North Central Cancer Treatment Group. Arch Surg. 1990;125:897-901
6. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet. 1995;345:939-944
7. Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology. 2008;134:1296-2310
8. Petersen VC, Baxter KJ, Love SB, et al. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut. 2002;51:65-69
9. Williams GT, Qurike P, Shepherd NA. Dataset for Colorectal Cancer 2nd ed. London, UK: Royal College of Pathologists; 2007. http://www.rcpath.org/ Resources/RCPath/Migrated%20Resources/Documents/G/G049-Colorectal Dataset-Sep07.pdf. Accessed September 27, 2013
10. Talbot IC, Ritchie S, Leighton MH, et al. The clinical significance of invasion of veins by rectal cancer. Br J Surg. 1980;67:439-442
11. Krasna MJ, Flancbaum L, Cody RP, et al. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer. 1988;61:1018-1023
12. Shirouzu K, Isomoto H, Kakegawa T, et al. A prospective clinicopathologic study of venous invasion in colorectal cancer. Am J Surg. 1991;162:216-222
13. Morris EJ, Maughan NJ, Forman D, et al. Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer?. The need for high quality pathology. Gut. 2007;56:1419-1425
14. Messenger DE, Driman DK, McLeod RS, et al. Current practice patterns among pathologists in the assessment of venous invasion in colorectal cancer. J Clin Pathol. 2011;64:983-989
15. Maughan NJ, Morris E, Forman D, et al. The validity of the Royal College of Pathologists' colorectal cancer minimum dataset within a population. Br J Cancer. 2007;97:1393-1398
16. Roxburgh CS, McMillan DC, Anderson JH, et al. Elastica staining for venous invasion results in superior prediction of cancer-specific survival in colorectal cancer. Ann Surg. 2010;252:989-997
17. MessengerDE, Driman DK, Kirsch R. Authors' response-The prognostic benefits of routine staining with elastica to increase detection of venous invasion in colorectal cancer specimens. J Clin Pathol. 2012;65:470
18. Messenger DE, Driman DK, Kirsch R. Developments in the assessment of venous invasion in colorectal cancer: Implications for future practice and patient outcome. Hum Pathol. 2012;43:965-973
19. Vass DG, Ainsworth R, Anderson JH, et al. The value of an elastic tissue stain in detecting venous invasion in colorectal cancer. J Clin Pathol. 2004;57:769-772
20. Kerr DJ, Midgley R. Defective mismatch repair in colon cancer: A prognostic or predictive biomarker?. J Clin Oncol. 2010;28:3210-3212
21. Graziano F, Cascinu S. Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: Howmuch evidence is enough?. Ann Oncol. 2003;14:1026-1038
22. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477
23. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-1471
24. Ellul P, Fogden E, Simpson CL, et al. Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: First round data from the first centre. Colorectal Dis. 2010;12:420-422
25. Roxburgh C, McTaggart F, Balsitis M, et al. The impact of the bowel screening programme on the diagnosis of colorectal cancer in Ayrshire and Arran. Colorectal Dis. 2013;1:34-41
26. Horgan PG, McMillan DC. Surgeons and selection of adjuvant therapy for node-negative colonic cancer. Br J Surg. 2010;97:1459-1460
27. Stewart CJ, Morris M, De Boer B, et al. Identification of serosal invasion and extramural venous invasion on review of Dukes' stage B colonic carcinomas and correlation with survival. Histopathology. 2007;51:372-378
28. Howlett CJ, Tweedie EJ, Driman DK. Use of an elastic stain to show venous invasion in colorectal carcinoma: A simple technique for detection of an important prognostic factor. J Clin Pathol. 2009;62:1021-1025
29. Inoue T, Mori M, Shimono R, et al. Vascular invasion of colorectal carcinoma readily visible with certain stains. Dis Colon Rectum. 1992;35:34-39
30. Kingston EF, Goulding H, Bateman AC. Vascular invasion is underrecognized in colorectal cancer using conventional hematoxylin and eosin staining. Dis Colon Rectum. 2007;50:1867-1872
31. Sejben I, Bori R, Cserni G. Venous invasion demonstrated by orcein staining of colorectal carcinoma specimens is associated with the development of distant metastasis. J Clin Pathol. 2010;63:575-578
32. Kirsch R, Riddell R, Pollett A, et al. Venous invasion in colorectal cancer: Impact of an elastin stain on detection and interobserver agreement among gastrointestinal and non-gastrointestinal pathologists.AmJ Surg Pathol. 2013;37:200-210
33. Association of Coloproctologists of Great Britain and Ireland. Guidelines for the Management of Colorectal Cancer. 3rd ed. London, UK: Association of Coloproctologists of Great Britain and Ireland. 2007. http://www.acpgbi .org.uk/content/uploads/2007-CC-Management-Guidelines.pdf. Accessed September 27, 2013
34. National Institute for Clinical Excellence: Guidelines for Management of Colorectal Cancer (Issued November 2012). http://www.nice.org.uk/nicemedia/live/ 13597/56957/56957.pdf. Accessed September 27, 2013
35. Horgan PG, McMillan DC. Surgeons and selection of adjuvant chemotherapy for colorectal cancer. Br J Surg. 2010;97:1459-1460.